Features

Webinar: Should I Stay or Should I Go? Exit Strategy Considerations for ODs

On Monday June 4th 2018 Canadian Eye Care Business Review hosted a panel discussion entitled: Should I Stay or Should I Go? Exit Strategy Considerations.

Preliminary Results in Clinical Trial for Dry AMD Implant

The first clinical human trial of an implant designed to treat dry AMD has produced preliminary results.

OGA’s Kemi: The “Pixel” Effect

Kemi is an abbreviation of the word “chemical” – a reference to the technique of chemical engraving, used to create a “pixel” effect on the front of these frames.

Kering and Balenciaga Partner Together

Kering Eyewear and Balenciaga announce their partnership for the development, production and worldwide distribution of Balenciaga sunglasses and...

Essilor Achieving Revenue Targets in First Quarter of 2018

Essilor announced that consolidated revenue for the first quarter of 2018 totaled €1,825 million ($2,282 million CAD), representing an increase of...

Webinar: Should I Stay or Should I Go? Exit Strategy Considerations for ODs

On Monday June 4th 2018 Canadian Eye Care Business Review hosted a panel discussion entitled: Should I Stay or Should I Go? Exit Strategy Considerations.

Preliminary Results in Clinical Trial for Dry AMD Implant

The first clinical human trial of an implant designed to treat dry AMD has produced preliminary results.

OGA’s Kemi: The “Pixel” Effect

Kemi is an abbreviation of the word “chemical” – a reference to the technique of chemical engraving, used to create a “pixel” effect on the front of these frames.

Kering and Balenciaga Partner Together

Kering Eyewear and Balenciaga announce their partnership for the development, production and worldwide distribution of Balenciaga sunglasses and...

Essilor Achieving Revenue Targets in First Quarter of 2018

Essilor announced that consolidated revenue for the first quarter of 2018 totaled €1,825 million ($2,282 million CAD), representing an increase of...

Webinar: Should I Stay or Should I Go? Exit Strategy Considerations for ODs

On Monday June 4th 2018 Canadian Eye Care Business Review hosted a panel discussion entitled: Should I Stay or Should I Go? Exit Strategy Considerations.

Preliminary Results in Clinical Trial for Dry AMD Implant

The first clinical human trial of an implant designed to treat dry AMD has produced preliminary results.

OGA’s Kemi: The “Pixel” Effect

Kemi is an abbreviation of the word “chemical” – a reference to the technique of chemical engraving, used to create a “pixel” effect on the front of these frames.

Kering and Balenciaga Partner Together

Kering Eyewear and Balenciaga announce their partnership for the development, production and worldwide distribution of Balenciaga sunglasses and...

Essilor Achieving Revenue Targets in First Quarter of 2018

Essilor announced that consolidated revenue for the first quarter of 2018 totaled €1,825 million ($2,282 million CAD), representing an increase of...

Webinar: Should I Stay or Should I Go? Exit Strategy Considerations for ODs

On Monday June 4th 2018 Canadian Eye Care Business Review hosted a panel discussion entitled: Should I Stay or Should I Go? Exit Strategy Considerations.

Preliminary Results in Clinical Trial for Dry AMD Implant

The first clinical human trial of an implant designed to treat dry AMD has produced preliminary results.

OGA’s Kemi: The “Pixel” Effect

Kemi is an abbreviation of the word “chemical” – a reference to the technique of chemical engraving, used to create a “pixel” effect on the front of these frames.

Kering and Balenciaga Partner Together

Kering Eyewear and Balenciaga announce their partnership for the development, production and worldwide distribution of Balenciaga sunglasses and...

Essilor Achieving Revenue Targets in First Quarter of 2018

Essilor announced that consolidated revenue for the first quarter of 2018 totaled €1,825 million ($2,282 million CAD), representing an increase of...